Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints

Journal of Proteome Research

Volumn 8, Issue 12, 2009, Pages 5580-5589

  Teul, Joanna ^a,b   Rupérez, Francisco J ^a   Garcia, Antonia ^a   Vaysse, Julie ^c   Balayssac, Stéphane ^c   Gilard, Véronique ^c   Malet Martino, Myriam ^c   Martin Ventura, Jose Luis ^d,e   Blanco Colio, Luis Miguel ^d,e   Tuñón, José ^d,e   Egido, Jesús ^d,e   Barbas, Coral ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

1H NMR; Biomarkers; Cardiovascular disease; GC MS; Insulin resistance; Metabolomics; Metabonomics; Pattern recognition

Indexed keywords

AMINO ACID; INSULIN;

ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INSULIN RESISTANCE; KNOWLEDGE; MASS FRAGMENTOGRAPHY; METABOLIC SYNDROME X; METABOLISM; METABOLITE; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

AMINO ACIDS; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; DISCRIMINANT ANALYSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLIC SYNDROME X; METABOLOME; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS;

EID: 71549114834     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900668v     Document Type: Article

References (33)

1. Choudhury, P.; Fuster, V.; Fayad, Z. A. Evolving invasive and noninvasive imaging techniques in atherothrombotic disease. In Atherothrombosis and Coronary Artery Disease; Fuster, V., Topol, E. J., Nabel, E. G., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, 2005; pp 703-715
2. Mahmarian, J. J. Computed Tomography of the Heart. In Atherothrombosis and Coronary Artery Disease; Fuster, V., Topol, E. J., Nabel, E. G., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, 2005; pp 731-743
3. Wang, T. J.; Gona, P.; Larson, M. G.; Tofler, G. H.; Levy, D.; Newton-Cheh, C.; Jacques, P.; Rifai, N.; Selhub, J.; Robins, S. J.; Benjamin, E. J.; D'Agostino, R. B.; Vasan, R. S. Multiple biomarkers for the prediction of first major cardiovascular events and death. N. Engl. J. Med. 2006, 355 (25), 2631-2639 (Pubitemid 44969122)
4. Gerszten, R. E.; Wang, T. J. The search for new cardiovascular biomarkers. Nature 2008, 451 (7181), 949-952
5. Vallejo, M.; García, A.; Tuñón, J.; García-Martínez, D.; Angulo, S.; Martin-Ventura, J. L.; Blanco-Colio, L. M.; Almeida, P.; Egido, J.; Barbas, C. Plasma fingerprinting with GC-MS in acute coronary syndrome. Anal. Bioanal. Chem. 2009, 394 (6), 1517-1524
6. Kanani, H.; Chrysanthopoulos, P.; Klapa, M. I. Standardizing GCMS metabolomics. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2008, 871 (2), 191-201.
7. Martino, R.; Gilard, V.; Desmoulin, F.; Malet-Martino, M. Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs. J. Pharm. Biomed. Anal. 2005, 38 (5), 871-891 (Pubitemid 41115794)
8. Serkova, N. J.; Niemann, C. U. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev. Mol. Diagn. 2006, 6 (5), 717-731
9. Ala-Korpela, M. Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool. Expert Rev. Mol. Diagn. 2007, 7 (6), 761-773 (Pubitemid 350171839)
10. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Metabonomics in pharmaceutical R&D. FEBS J. 2007, 274 (5), 1140-1151
11. Moco, S.; Vervoorta, J.; Bino, R. J.; De Vos, R. C. H.; Binod, R. Metabolomics technologies and metabolite identification. Trends Anal. Chem. 2007, 26 (9), 855-866.
12. Raveh, A. On the use of the inverse of the correlation matrix in multivariate data analysis. Am. Statist. 1985, 39, 39-42.
13. Noda, I. Two-Dimensional Infrared Spectroscopy. J. Chem Am Soc. 1989, 111, 8116-8118
14. Brüschweiler, R.; Zhang, F. Covariance nuclear magnetic resonance spectroscopy. J. Chem. Phys. 2004, 120 (11), 5253-5260
15. Cloarec, O.; Dumas, M. E.; Craig, A.; Barton, R. H.; Trygg, J.; Hudson, J.; Blancher, C.; Gauguier, D.; Lindon, J. C.; Holmes, E.; Nicholson, J. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal. Chem. 2005, 77 (5), 1282-1289 (Pubitemid 40327865)
16. Crockford, D. J.; Holmes, E.; Lindon, J. C.; Plumb, R. S.; Zirah, S.; Bruce, S. J.; Rainville, P.; Stumpf, C. L.; Nicholson, J. K. Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal. Chem. 2006, 78 (2), 363-371
17. Nicholson, J. K.; Foxall, P. J.; Spraul, M.; Farrant, R. D.; Lindon, J. C. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem. 1995, 67 (5), 793-811.
18. Wishart, D. S.; Lewis, M. J.; Morrissey, J. A.; Flegel, M. D.; Jeroncic, K.; Xiong, Y.; Cheng, D.; Eisner, R.; Gautam, B.; Tzur, D.; Sawhney, S.; Bamforth, F.; Greiner, R.; Li, L. The human cerebrospinal fluid metabolome. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2008, 871 (2), 164-173
19. 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS. Mol. Biosyst. 2009, 5 (2), 180-190
20. García-Pérez, I.; Whitfield, P. J.; Bartlett, A. P.; Angulo, S.; Legido-Quigley, C.; Hanna-Brown, M.; Barbas, C. Metabolic fingerprinting of Schistosoma mansoni infection in mice urine with capillary electrophoresis. Electrophoresis 2008, 29 (15), 3201-3206
21. Angulo, S.; García-Pérez, I.; Legido-Quigley, C.; Barbas, C. The autocorrelation matrix probing biochemical relationships after metabolic fingerprinting with CE. Electrophoresis 2009, 30 (7), 1221-1227
22. Rajalahti, T.; Arneberg, R.; Berven, F. S.; Myhr, K.-M.; Ulvik, R. J.; Kvalheim, O. M. Biomarker discovery in mass spectral profiles by means of selectivity ratio plot. Chemom. Intell. Lab. Syst. 2009, 95 (1), 35-48.
23. HSC-2D PAGE, from Heart Science Harefield Hospital; http://www.doc.ic.ac. uk/vip/hsc-2dpage/#individual, accessed 27/07/09.
24. HEART-2D PAGE, from German Heart Institute Berlin; http://userpage. chemie.fu-berlin.de/~pleiss/, accessed 27/07/09.
25. Vozarova, B.; Stefan, N.; Lindsay, R.; Saremi, A.; Pratley, R.; Bogardus, C.; Tataranni, P. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002, 51 (6), 1889-1895 (Pubitemid 34564303)
26. Adibi, P.; Sadeghi, M.; Mahsa, M.; Rozati, G.; Mohseni, M. Prediction of coronary atherosclerotic disease with liver transaminase level. Liver Int. 2007, 27 (7), 895-900. (Pubitemid 47261942)
27. Reaven, G. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37 (12), 1595-1607
28. Wascher, T. C.; Sourij, H.; Roth, M.; Dittrich, P. Prevalence of pathological glucose metabolism in patients undergoing elective coronary angiography. Atherosclerosis 2004, 176 (2), 419-421 (Pubitemid 39369535)
29. Lusis, A. J.; Attie, A. D.; Reue, K. Metabolic syndrome: from epidemiology to systems biology. Nat. Rev. Genet. 2008, 9 (11), 819-830
30. McFarlane, S. I.; Banerji, M.; Sowers, J. R. Insulin resistance and cardiovascular disease. J. Clin. Endocrinol. Metab. 2001, 86 (2), 713-718
31. Ginsberg, H. N. Insulin resistance and cardiovascular disease. J. Clin. Invest. 2000, 106 (4), 453-458
32. Reaven, G. M. Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor's clothes fit. Diabetes Care 2004, 27 (4), 1011-1012 (Pubitemid 38420232)
33. Schindler, C. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis. Ther. Adv. Cardiovasc. Dis. 2007, 1 (1), 7-26.